Legend Biotech Corp

LEGN · NASDAQ

Pharmaceutical Preparation Manufacturing

Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. The team of over 800 employees across the United States, China and Europe, along with its differentiated technology, global development, and manufacturing strategies and expertise, provide us with the strong potential to discover, develop, and manufacture cutting edge cell therapies for patients in need.

ESG Scores

Overall ESG

4.5

Environmental

7.1

Social

3.7

Governance

4.3

Gender Diversity

Female Directors0.2%

Female Executives1%

Market Data

Price$23.23+2.06 (+9.73%)

Market Cap$3.92B

P/E Ratio—

EPS$—

52W High$45.30

52W Low$16.24

Beta0.19